OTC analgesic alcohol warning health risk communication to be assessed in FDA study.
This article was originally published in The Tan Sheet
Executive Summary
OTC ANALGESIC ALCOHOL WARNING HEALTH RISK COMMUNICATION will be assessed in FDA's upcoming consumer survey of OTC drug labeling. The agency says in an Aug. 6 description of the proposed research that its purpose will be "to investigate how various methods of phrasing information in the alcohol warning influences consumers' perception of the product's risk." The study will assess the adequacy of the currently used labeling statement: "Alcohol Warning: If you generally consume three or more alcohol-containing drinks per day, you should consult your physician for advice on when and how you should take [this product] and other pain relievers."